MANE

Veradermics, Inc

Healthcare · Biotechnology

$342.81 sample

+4.10 (+1.21%) 1D

Market cap

$490.0B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-02

Alerts

8

Price$342.81 +13.54% 3M daily closessample

342.88301.92

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 07INSInsider buy: 10% owner
Oct 02SECDEF 14A filed
Sep 29INSInsider sell: Director
Sep 21INSInsider buy: Director
Sep 15INSInsider buy: General Counsel
Sep 08SECForm 144 filed
Aug 31SEC10-Q filed
Aug 21INSInsider sell: EVP, Operations

Sign up to see the real MANE record →

Company facts

SEC EDGAR registration

Name: Veradermics, Inc
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -57sample, -100 to +100
Reporting currency: USD

Who is positioning in MANE

sample

Insiders: 22 insider transactions over 90 days, net selling, $767.7M
Congress: 3 members traded over 90 days
Institutions · 13F: 8 funds hold $7.5B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$30.4B +11.3% y/y

Q4 2024Q3 2026

Inventory$18.2B +5.2% y/y

Q4 2024Q3 2026

Accounts receivable$13.6B +13.2% y/y

Q4 2024Q3 2026

Total debt$38.4B +12.9% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $60.0B +0.6% 3M
Sample peer B: $280.6B -1.3% 3M
Sample peer C: $59.9B +15.9% 3M
Sample peer D: $218.5B +10.9% 3M
Sample peer E: $360.4B -5.7% 3M